| abstract |
The present invention relates to ZD6474 monohydrate, a method for preparing ZD6474 monohydrate, a pharmaceutical composition comprising ZD6474 monohydrate as an active ingredient, a medicament for use in the production of anti-angiogenic and / or vascular permeability-reducing effects in warm-blooded animals such as humans. The use of ZD6474 monohydrate in the manufacture of and the use of ZD6474 monohydrate in a method associated with neovascularization and / or increased vascular permeability in warm blooded animals such as humans, such as cancer. |